Načítá se...

Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

Improving clinical outcomes among high risk Class III β thalassemia major patients (Class IIIHR) receiving an allogeneic SCT remains a challenge. From October, 2009 a treosulfan based regimen (TreoFluT) was used for all consecutive Class III patients (n = 50). The clinical outcomes were compared wit...

Celý popis

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Mathews, Vikram, George, Biju, Viswabandya, Auro, Abraham, Aby, Ahmed, Rayaz, Ganapule, Abhijeet, Sindhuvi, Eunice, Lakshmi, Kavitha M., Srivastava, Alok
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science 2013
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3637210/ https://ncbi.nlm.nih.gov/pubmed/23637873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0061637
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo otaguje tento záznam!

Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

Podobné jednotky